As House Republicans aim to finalize President Trump's sweeping bill, fierce debates over tax cuts and safety net reforms create uncertainty. Key issues like Medicaid changes and the SALT deduction could determine the bill's fate.
Pharma faces a daunting challenge as Trump takes bold steps to cut drug prices. With RFK Jr. praising the move, is bipartisanship on the horizon or will the industry fight back?
In a surprising turn of events, Stephen Hemsley is back as CEO of UnitedHealth after the abrupt departure of current leader Witty. The company faces significant challenges, including recent cyberattacks and rising medical costs.
House Republicans have unveiled a controversial plan to cut $880 billion from Medicaid to fund $4.5 trillion in tax breaks, igniting a fierce debate over health coverage for millions of Americans.
The GOP's new Medicaid proposal, led by Chair Brett Guthrie, sparks controversy as it could leave over 8.6 million uninsured. While some praise the plan for protecting vulnerable populations, critics warn of devastating cuts and fiscal impacts.
In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
President Trump unveils a groundbreaking executive order aimed at slashing U.S. drug prices by matching them to those in developed countries. Will this initiative reshape the pharmaceutical landscape and benefit American patients?
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
President Trump signs an executive order reviving the 'most favored nation' policy to slash drug costs by linking U.S. prices to lower prices abroad. Will this finally bring relief to American patients?
